Skip Nav Destination
Treatment and evaluation of CLL: a complicated affair
Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML
HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation
Issue Archive
February 1 2006
In this Issue
Table of Contents
INSIDE BLOOD
CLINICAL TRIALS AND OBSERVATIONS
Treatment and evaluation of CLL: a complicated affair
Clinical Trials & Observations
BLOOD WORK
PERSPECTIVES
Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia
Jacques-Louis Binet,Federico Caligaris-Cappio,Daniel Catovsky,Bruce Cheson,Tom Davis,Guillaume Dighiero,Hartmut Döhner,Michael Hallek,Peter Hillmen,Michael Keating,Emili Montserrat,Thomas J. Kipps,Kanti Rai,for the International Workshop on Chronic Lymphocytic Leukemia (IWCLL)-initiated working group on prognostic and diagnostic parameters in CLL
REVIEW ARTICLES
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center
Clinical Trials & Observations
Yasuhiro Oki,Hagop M. Kantarjian,Xian Zhou,Jorge Cortes,Stefan Faderl,Srdan Verstovsek,Susan O'Brien,Charles Koller,Miloslav Beran,B. Nebiyou Bekele,Sherry Pierce,Deborah Thomas,Farhad Ravandi,William G. Wierda,Francis Giles,Alessandra Ferrajoli,Elias Jabbour,Michael J. Keating,Carlos E. Bueso-Ramos,Elihu Estey,Guillermo Garcia-Manero
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia
Clinical Trials & Observations
Barbara F. Eichhorst,Raymonde Busch,Georg Hopfinger,Rita Pasold,Manfred Hensel,Cordelia Steinbrecher,Siegfried Siehl,Ulrich Jäger,Manuela Bergmann,Stephan Stilgenbauer,Carmen Schweighofer,Clemens M. Wendtner,Hartmut Döhner,Günter Brittinger,Bertold Emmerich,Michael Hallek,the German CLL Study Group
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States
Clinical Trials & Observations
Brief Report
Ola Landgren,Gloria Gridley,Ingemar Turesson,Neil E. Caporaso,Lynn R. Goldin,Dalsu Baris,Thomas R. Fears,Robert N. Hoover,Martha S. Linet
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Arrested natural killer cell development associated with transgene insertion into the Atf2 locus
Sungjin Kim,Yun-Jeong Song,Darryl A. Higuchi,Hyunseok P. Kang,Jennifer R. Pratt,Liping Yang,Caron M. Hong,Jennifer Poursine-Laurent,Koho Iizuka,Anthony R. French,John B. Sunwoo,Shunsuke Ishii,Andreas M. Reimold,Wayne M. Yokoyama
Coordination between NF-κB family members p50 and p52 is essential for mediating LTβR signals in the development and organization of secondary lymphoid tissues
James C. Lo,Soumen Basak,Ethan S. James,Raechel S. Quiambo,Marcus C. Kinsella,Maria-Luisa Alegre,Falk Weih,Guido Franzoso,Alexander Hoffmann,Yang-Xin Fu
NEOPLASIA
Antimyeloma activity of heat shock protein-90 inhibition
Constantine S. Mitsiades,Nicholas S. Mitsiades,Ciaran J. McMullan,Vassiliki Poulaki,Andrew L. Kung,Faith E. Davies,Gareth Morgan,Masaharu Akiyama,Reshma Shringarpure,Nikhil C. Munshi,Paul G. Richardson,Teru Hideshima,Dharminder Chauhan,Xuesong Gu,Charles Bailey,Marie Joseph,Towia A. Libermann,Neal S. Rosen,Kenneth C. Anderson
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
Lisa M. Rimsza,Robin A. Roberts,Elias Campo,Thomas M. Grogan,Silvia Bea,Itziar Salaverria,Andreas Zettl,Andreas Rosenwald,German Ott,H. Konrad Muller-Hermelink,Jan Delabie,Richard I. Fisher,Joseph M. Unger,Michael LeBlanc,Louis M. Staudt,Elaine S. Jaffe,Randy D. Gascoyne,Wing C. Chan,Dennis D. Weisenburger,Timothy Greiner,Rita M. Braziel,Thomas P. Miller
Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV
Maria Grazia Narducci,Enrico Scala,Antonella Bresin,Elisabetta Caprini,Maria Cristina Picchio,Daniele Remotti,Gianluca Ragone,Francesca Nasorri,Marina Frontani,Diego Arcelli,Stefano Volinia,Giuseppe Alfonso Lombardo,Giannandrea Baliva,Monica Napolitano,Giandomenico Russo
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
Clinical Trials & Observations
Monika Brüggemann,Thorsten Raff,Thomas Flohr,Nicola Gökbuget,Makoto Nakao,Jo Droese,Silke Lüschen,Christiane Pott,Matthias Ritgen,Urban Scheuring,Heinz-August Horst,Eckhard Thiel,Dieter Hoelzer,Claus R. Bartram,Michael Kneba,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML
Clinical Trials & Observations
Daniel J. Pearce,David Taussig,Kazem Zibara,Lan-Lan Smith,Christopher M. Ridler,Claude Preudhomme,Bryan D. Young,Ama Z. Rohatiner,T. Andrew Lister,Dominique Bonnet
PHAGOCYTES
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSFUSION MEDICINE
TRANSPLANTATION
HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants
Clinical Trials & Observations
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation
Clinical Trials & Observations
Brief Report
Mark Cook,David Briggs,Charles Craddock,Premini Mahendra,Donald Milligan,Christopher Fegan,Philip Darbyshire,Sarah Lawson,Elizabeth Boxall,Paul Moss
CORRESPONDENCE
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals